FRESENIUS MEDICAL CARE AG (1FME.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1FME - DE0005785802 - Common Stock
40.4 EUR
-1.49 (-3.56%)
1FME gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 29 industry peers in the Health Care Providers & Services industry. 1FME has an average financial health and profitability rating. 1FME has a decent growth rate and is not valued too expensively. Finally 1FME also has an excellent dividend rating. These ratings could make 1FME a good candidate for dividend investing.
1. Profitability
1.1 Basic Checks
1FME had positive earnings in the past year.
1FME had a positive operating cash flow in the past year.
In the past 5 years 1FME has always been profitable.
1FME had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 2.33%, 1FME perfoms like the industry average, outperforming 48.48% of the companies in the same industry.
1FME has a Return On Equity (5.55%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 3.95%, 1FME is in line with its industry, outperforming 45.45% of the companies in the same industry.
1FME had an Average Return On Invested Capital over the past 3 years of 3.14%. This is below the industry average of 6.33%.
The last Return On Invested Capital (3.95%) for 1FME is above the 3 year average (3.14%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROIC | 3.95% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
1FME has a better Profit Margin (3.66%) than 63.64% of its industry peers.
In the last couple of years the Profit Margin of 1FME has declined.
1FME's Operating Margin of 7.19% is fine compared to the rest of the industry. 1FME outperforms 60.61% of its industry peers.
1FME's Operating Margin has declined in the last couple of years.
1FME has a Gross Margin (25.00%) which is in line with its industry peers.
In the last couple of years the Gross Margin of 1FME has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1FME is destroying value.
Compared to 1 year ago, 1FME has about the same amount of shares outstanding.
Compared to 5 years ago, 1FME has less shares outstanding
The debt/assets ratio for 1FME has been reduced compared to a year ago.
2.2 Solvency
1FME has an Altman-Z score of 2.20. This is not the best score and indicates that 1FME is in the grey zone with still only limited risk for bankruptcy at the moment.
1FME has a Altman-Z score (2.20) which is comparable to the rest of the industry.
The Debt to FCF ratio of 1FME is 5.97, which is a neutral value as it means it would take 1FME, 5.97 years of fcf income to pay off all of its debts.
1FME's Debt to FCF ratio of 5.97 is fine compared to the rest of the industry. 1FME outperforms 72.73% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that 1FME is somewhat dependend on debt financing.
1FME has a better Debt to Equity ratio (0.73) than 69.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Altman-Z | 2.2 |
ROIC/WACC0.7
WACC5.67%
2.3 Liquidity
1FME has a Current Ratio of 1.36. This is a normal value and indicates that 1FME is financially healthy and should not expect problems in meeting its short term obligations.
1FME has a Current ratio of 1.36. This is in the better half of the industry: 1FME outperforms 69.70% of its industry peers.
1FME has a Quick Ratio of 1.36. This is a bad value and indicates that 1FME is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.00, 1FME is doing good in the industry, outperforming 63.64% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
1FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.77%, which is quite good.
The Earnings Per Share has been decreasing by -6.43% on average over the past years.
1FME shows a small growth in Revenue. In the last year, the Revenue has grown by 2.10%.
The Revenue has been growing slightly by 2.04% on average over the past years.
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
3.2 Future
Based on estimates for the next years, 1FME will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.73% on average per year.
1FME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.08% yearly.
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y13.73%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y4.08%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.74 indicates a reasonable valuation of 1FME.
87.88% of the companies in the same industry are more expensive than 1FME, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.00. 1FME is valued rather cheaply when compared to this.
1FME is valuated reasonably with a Price/Forward Earnings ratio of 9.74.
Based on the Price/Forward Earnings ratio, 1FME is valued cheaply inside the industry as 90.91% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of 1FME to the average of the S&P500 Index (23.70), we can say 1FME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.74 | ||
| Fwd PE | 9.74 |
4.2 Price Multiples
60.61% of the companies in the same industry are cheaper than 1FME, based on the Enterprise Value to EBITDA ratio.
1FME's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.51 | ||
| EV/EBITDA | 10.52 |
4.3 Compensation for Growth
1FME's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 1FME's earnings are expected to grow with 13.16% in the coming years.
PEG (NY)0.49
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y13.16%
5. Dividend
5.1 Amount
1FME has a Yearly Dividend Yield of 3.54%.
1FME's Dividend Yield is rather good when compared to the industry average which is at 1.45. 1FME pays more dividend than 93.94% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, 1FME pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.54% |
5.2 History
The dividend of 1FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
58.83% of the earnings are spent on dividend by 1FME. This is a bit on the high side, but may be sustainable.
The dividend of 1FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP58.83%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
BIT:1FME (12/15/2025, 7:00:00 PM)
40.4
-1.49 (-3.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.88%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.71B
Revenue(TTM)19.64B
Net Income(TTM)718.19M
Analysts57.93
Price Target47.84 (18.42%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.54% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP58.83%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.52%
Min EPS beat(2)14.16%
Max EPS beat(2)14.89%
EPS beat(4)4
Avg EPS beat(4)17.81%
Min EPS beat(4)14.16%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)16.37%
EPS beat(12)10
Avg EPS beat(12)13.79%
EPS beat(16)12
Avg EPS beat(16)10.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.52%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)-1.71%
Revenue beat(4)2
Avg Revenue beat(4)0.94%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-3.67%
PT rev (3m)-7.99%
EPS NQ rev (1m)-0.91%
EPS NQ rev (3m)-2.96%
EPS NY rev (1m)2.83%
EPS NY rev (3m)6.76%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)0.93%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.74 | ||
| Fwd PE | 9.74 | ||
| P/S | 1.21 | ||
| P/FCF | 13.51 | ||
| P/OCF | 9.44 | ||
| P/B | 1.83 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.52 |
EPS(TTM)3.76
EY9.31%
EPS(NY)4.15
Fwd EY10.26%
FCF(TTM)2.99
FCFY7.4%
OCF(TTM)4.28
OCFY10.59%
SpS33.47
BVpS22.07
TBVpS-3.21
PEG (NY)0.49
PEG (5Y)N/A
Graham Number43.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.33% | ||
| ROE | 5.55% | ||
| ROCE | 5.62% | ||
| ROIC | 3.95% | ||
| ROICexc | 4.26% | ||
| ROICexgc | 11.65% | ||
| OM | 7.19% | ||
| PM (TTM) | 3.66% | ||
| GM | 25% | ||
| FCFM | 8.93% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score5
Asset Turnover0.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.73 | ||
| Debt/FCF | 5.97 | ||
| Debt/EBITDA | 3.12 | ||
| Cap/Depr | 47.15% | ||
| Cap/Sales | 3.85% | ||
| Interest Coverage | 3.87 | ||
| Cash Conversion | 83.24% | ||
| Profit Quality | 244.33% | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.2 |
F-Score5
WACC5.67%
ROIC/WACC0.7
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)16.77%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%34.15%
EPS Next Y21.73%
EPS Next 2Y12.96%
EPS Next 3Y13.16%
EPS Next 5Y13.73%
Revenue 1Y (TTM)2.1%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%2.63%
Revenue Next Year1.57%
Revenue Next 2Y2.26%
Revenue Next 3Y2.91%
Revenue Next 5Y4.08%
EBIT growth 1Y-3.43%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.22%
EBIT Next 3Y29.78%
EBIT Next 5Y18.68%
FCF growth 1Y-5.89%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y0.06%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / 1FME.MI FAQ
What is the fundamental rating for 1FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to 1FME.MI.
Can you provide the valuation status for FRESENIUS MEDICAL CARE AG?
ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (1FME.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for FRESENIUS MEDICAL CARE AG?
FRESENIUS MEDICAL CARE AG (1FME.MI) has a profitability rating of 5 / 10.
What are the PE and PB ratios of FRESENIUS MEDICAL CARE AG (1FME.MI) stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (1FME.MI) is 10.74 and the Price/Book (PB) ratio is 1.83.
Can you provide the financial health for 1FME stock?
The financial health rating of FRESENIUS MEDICAL CARE AG (1FME.MI) is 5 / 10.